Evidence map›Paper›PMID 40676160›Full record

ArticleScientific reports2025

Development and characterization of pegylated Fe

Showket Yahya, Sangeetha Pushpanathan, Shafqat Jan, Nazia Chaudhary, Rasik Parray, Khushboo A Gandhi, Kumaran Thangavel, Kathiravan Krishnan, Ganapasam Sudhandiran

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. In Vitro Antitumor Effects of Melittin Attached to FeMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Showket YahyaAdvanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India. showket.yahya@actrec.gov.in.
Sangeetha Pushpanathan *Department of Biotechnology, University of Madras, Guindy Campus, Chennai, India.
Shafqat Jan *Department of Zoology, Saifia science College, Barkatullah University, Bhopal, MP, India.
Nazia Chaudhary *Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India.
Rasik ParrayDepartment of Nuclear Physics, University of Madras, Guindy Campus, Chennai, India.
Khushboo A GandhiAdvanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India.
Kumaran ThangavelDepartment of Biotechnology, University of Madras, Guindy Campus, Chennai, India.
Kathiravan KrishnanDepartment of Biotechnology, University of Madras, Guindy Campus, Chennai, India.
Ganapasam SudhandiranCell Biology Laboratory, Department of Biochemistry, University of Madras, Guindy Campus, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of effective macromolecular drug delivery systems remains crucial for improving therapeutic outcomes in cancer treatment. This study presents the design, synthesis, and characterization of a novel polymer-modified magnetic nanocarrier system incorporating caffeic acid phenethyl ester (CAPE). We synthesized Fe

Indexed as

Caffeic AcidsColorectal NeoplasmsHyperthermia, InducedMagnetite NanoparticlesPhenylethyl AlcoholPolyethylene GlycolsAnimalsCell ProliferationDrug CarriersDrug Delivery SystemsHT29 CellsHumansMicecaffeic acid phenethyl esterCaffeic AcidsDrug CarriersMagnetite NanoparticlesPhenylethyl AlcoholPolyethylene GlycolsCaffeic acid phenethyl esterColorectal cancerDrug delivery systemsHyperthermiaMacromolecular therapeuticsMagnetic nanocarriersPEGylationPolymer-drug conjugates

Identifiers

PMID40676160
PMCPMC12271528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.